-
1
-
-
36448936367
-
EAU guidelines on prostate cancer
-
Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 53 (2008) 68-80
-
(2008)
Eur Urol
, vol.53
, pp. 68-80
-
-
Heidenreich, A.1
Aus, G.2
Bolla, M.3
-
2
-
-
26444462106
-
Optimising hormone therapy in advanced disease
-
Boccon-Gibod L. Optimising hormone therapy in advanced disease. Eur Urol Suppl 4 8 (2005) 21-29
-
(2005)
Eur Urol Suppl
, vol.4
, Issue.8
, pp. 21-29
-
-
Boccon-Gibod, L.1
-
3
-
-
33845645525
-
The current status of intermittent androgen deprivation (IAD) therapy for prostate cancer: putting IAD under the spotlight
-
Tunn U. The current status of intermittent androgen deprivation (IAD) therapy for prostate cancer: putting IAD under the spotlight. BJU Int 99 Suppl 1 (2007) 19-22
-
(2007)
BJU Int
, vol.99
, Issue.SUPPL. 1
, pp. 19-22
-
-
Tunn, U.1
-
4
-
-
33745172826
-
Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer
-
Mottet N., Prayer-Galetti T., Hammerer P., Kattan M.W., and Tunn U. Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer. BJU Int 98 (2006) 20-27
-
(2006)
BJU Int
, vol.98
, pp. 20-27
-
-
Mottet, N.1
Prayer-Galetti, T.2
Hammerer, P.3
Kattan, M.W.4
Tunn, U.5
-
5
-
-
0037299782
-
Side effects of androgen deprivation therapy: monitoring and minimizing toxicity
-
Higano C.S. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 61 Suppl 1 (2003) 32-38
-
(2003)
Urology
, vol.61
, Issue.SUPPL. 1
, pp. 32-38
-
-
Higano, C.S.1
-
6
-
-
33749058933
-
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
-
Keating N.L., O'Malley A.J., and Smith M.R. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24 (2006) 4448-4456
-
(2006)
J Clin Oncol
, vol.24
, pp. 4448-4456
-
-
Keating, N.L.1
O'Malley, A.J.2
Smith, M.R.3
-
7
-
-
34347271955
-
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions
-
D'Amico A.V., Denham J.W., Crook J., et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 25 (2007) 2420-2425
-
(2007)
J Clin Oncol
, vol.25
, pp. 2420-2425
-
-
D'Amico, A.V.1
Denham, J.W.2
Crook, J.3
-
8
-
-
34648828214
-
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
-
Saigal C.S., Gore J.L., Krupski T.L., Hanley J., Schonlau M., and Litwin M.S. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 110 (2007) 1493-1500
-
(2007)
Cancer
, vol.110
, pp. 1493-1500
-
-
Saigal, C.S.1
Gore, J.L.2
Krupski, T.L.3
Hanley, J.4
Schonlau, M.5
Litwin, M.S.6
-
9
-
-
34548443017
-
The role of intermittent androgen deprivation in prostate cancer
-
Boccon-Gibod L., Hammerer P., Madersbacher S., Mottet N., Prayer-Galetti T., and Tunn U. The role of intermittent androgen deprivation in prostate cancer. BJU Int 100 (2007) 738-743
-
(2007)
BJU Int
, vol.100
, pp. 738-743
-
-
Boccon-Gibod, L.1
Hammerer, P.2
Madersbacher, S.3
Mottet, N.4
Prayer-Galetti, T.5
Tunn, U.6
-
10
-
-
0028808382
-
The final analysis of the EORTC Genito-Urinary Tract Cancer Co-operative Group Phase III clinical trial (Protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate, and low dose stilboestrol in the management of metastatic carcinoma of the prostate
-
Robinson M.R., Smith P.H., Richards B., Newling D.W., de Pauw M., and Sylvester R. The final analysis of the EORTC Genito-Urinary Tract Cancer Co-operative Group Phase III clinical trial (Protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate, and low dose stilboestrol in the management of metastatic carcinoma of the prostate. Eur Urol 28 (1995) 273-283
-
(1995)
Eur Urol
, vol.28
, pp. 273-283
-
-
Robinson, M.R.1
Smith, P.H.2
Richards, B.3
Newling, D.W.4
de Pauw, M.5
Sylvester, R.6
-
11
-
-
0027416692
-
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen
-
Akakura K., Bruchovsky N., Goldenberg S.L., Rennie P.S., Buckley A.R., and Sullivan L.D. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer 71 (1993) 2782-2790
-
(1993)
Cancer
, vol.71
, pp. 2782-2790
-
-
Akakura, K.1
Bruchovsky, N.2
Goldenberg, S.L.3
Rennie, P.S.4
Buckley, A.R.5
Sullivan, L.D.6
-
12
-
-
0025246690
-
Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma
-
Bruchovsky N., Rennie P.S., Coldman A.J., Goldenberg S.L., To M., and Lawson D. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res 50 (1990) 2275-2282
-
(1990)
Cancer Res
, vol.50
, pp. 2275-2282
-
-
Bruchovsky, N.1
Rennie, P.S.2
Coldman, A.J.3
Goldenberg, S.L.4
To, M.5
Lawson, D.6
-
13
-
-
0028245279
-
Effect of tumour progression on the androgenic regulation of the androgen receptor. TRPM-2 and YPT1 genes in the Shionogi carcinoma
-
Rennie P.S., Bruchovsky N., Akakura K., et al. Effect of tumour progression on the androgenic regulation of the androgen receptor. TRPM-2 and YPT1 genes in the Shionogi carcinoma. J Steroid Biochem Mol Biol 50 (1994) 31-40
-
(1994)
J Steroid Biochem Mol Biol
, vol.50
, pp. 31-40
-
-
Rennie, P.S.1
Bruchovsky, N.2
Akakura, K.3
-
14
-
-
0027239899
-
Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol
-
Bruchovsky N., Goldenberg S.L., Akakura K., and Rennie P.S. Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol. Cancer 72 (1993) 1685-1691
-
(1993)
Cancer
, vol.72
, pp. 1685-1691
-
-
Bruchovsky, N.1
Goldenberg, S.L.2
Akakura, K.3
Rennie, P.S.4
-
15
-
-
0029656221
-
Biochemical and pathological effects of 8 mo of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer
-
Gleave M.E., Goldenberg S.L., Jones E.C., Bruchovsky N., and Sullivan L.D. Biochemical and pathological effects of 8 mo of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer. J Urol 155 (1996) 213-219
-
(1996)
J Urol
, vol.155
, pp. 213-219
-
-
Gleave, M.E.1
Goldenberg, S.L.2
Jones, E.C.3
Bruchovsky, N.4
Sullivan, L.D.5
-
16
-
-
33645341444
-
Enhancement of intermittent androgen ablation by "off-cycle" maintenance with finasteride in LNCaP prostate cancer xenograft model
-
Eggener S.E., Stern J.A., Jain P.M., et al. Enhancement of intermittent androgen ablation by "off-cycle" maintenance with finasteride in LNCaP prostate cancer xenograft model. Prostate 66 (2006) 495-502
-
(2006)
Prostate
, vol.66
, pp. 495-502
-
-
Eggener, S.E.1
Stern, J.A.2
Jain, P.M.3
-
17
-
-
34247111243
-
International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients
-
Shaw G.L., Wilson P., Cuzick J., et al. International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients. BJU Int 99 (2007) 1056-1065
-
(2007)
BJU Int
, vol.99
, pp. 1056-1065
-
-
Shaw, G.L.1
Wilson, P.2
Cuzick, J.3
-
18
-
-
33748465540
-
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162)
-
Hussain M., Tangen C.M., Higano C., et al. Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162). J Clin Oncol 24 (2006) 3984-3990
-
(2006)
J Clin Oncol
, vol.24
, pp. 3984-3990
-
-
Hussain, M.1
Tangen, C.M.2
Higano, C.3
-
19
-
-
34948835932
-
Randomised prospective study of intermittent versus continuous androgen suppression in advanced prostate cancer
-
abstract 5015
-
Miller K., Steiner U., Lingnau A., et al. Randomised prospective study of intermittent versus continuous androgen suppression in advanced prostate cancer. J Clin Oncol 25 (2007) 2385 abstract 5015
-
(2007)
J Clin Oncol
, vol.25
, pp. 2385
-
-
Miller, K.1
Steiner, U.2
Lingnau, A.3
-
21
-
-
48849104783
-
Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation
-
Salonen A.J., Viitanen J., Lundstedt S., la-Opas M., Taari K., and Tammela T.L. Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation. J Urol 180 (2008) 915-919
-
(2008)
J Urol
, vol.180
, pp. 915-919
-
-
Salonen, A.J.1
Viitanen, J.2
Lundstedt, S.3
la-Opas, M.4
Taari, K.5
Tammela, T.L.6
-
22
-
-
3442876782
-
Intermittent is as effective as continuous androgen deprivation in patients with PSA relapse after radical prostatectomy (RP)
-
abstract 1458
-
Tunn U., Kurek R., Kienle E., and Maubach L. Intermittent is as effective as continuous androgen deprivation in patients with PSA relapse after radical prostatectomy (RP). J Urol 171 (2004) 384 abstract 1458
-
(2004)
J Urol
, vol.171
, pp. 384
-
-
Tunn, U.1
Kurek, R.2
Kienle, E.3
Maubach, L.4
-
23
-
-
54549109116
-
Intermittent androgen deprivation in patients with PSA relapse after radical prostatectomy-final results of a European randomized prospective phase-III clinical trial AUO study AP 06/95, EC 507
-
abstract 600
-
Tunn U.W., Canepa G., Hillger H., and Fuchs W. Intermittent androgen deprivation in patients with PSA relapse after radical prostatectomy-final results of a European randomized prospective phase-III clinical trial AUO study AP 06/95, EC 507. J Urol 177 (2007) 201 abstract 600
-
(2007)
J Urol
, vol.177
, pp. 201
-
-
Tunn, U.W.1
Canepa, G.2
Hillger, H.3
Fuchs, W.4
|